• Announcement
  • What's New
  • Background
  • Objectives
  • Eligible Activities
  • Activity Cycle
  • Forms to Download
  • Frequently Asked Questions
  • Contact Us

This initiative is in partnership between the Australian Government and the Government of the People's Republic of China

 



An Australian Government, AusAID Initiative

 



Managed for AusAID by the Burnet Institute in association with HLSP

|   

Please enter a search term to begin your search.

Launch of CAHHF activity “Investigation of prevention and treatment strategies for common gynecological diseases in Chinese rural areas”

The project Investigation of prevention and treatment strategies for common gynecological diseases in Chinese rural areas (HSS18) was successfully launched in Beijing on 2nd July, 2009. Implemented by the National Center of Women and Children’s Health, China CDC, in collaboration with Australian Griffith University, this activity aims to expand disease prevention and treatment for women in rural and remote areas.

Dr. Nie Jiangang, Director of the Division of European, American and Oceanian Affairs, MOH, opened the ceremony by confirming CAHHF’s contribution to Australian and Chinese collaborations in the field of technological research and institutional cooperation. Mr. Grand Morrison, First Secretary, AusAID Beijing, announced that this project is contributing to strengthen maternal and children health and thereby improving China’s progress towards MDGs 4 and 5.

Ms. Song Li, Deputy Director of Division of MCH and Community Health, MOH, provided the group with an analysis of the current situation of maternal disease in China, and put forward recommendations for the activity’s implementation. Following the opening speeches, Ms. Wang Linhong, Deputy Director of National Center of MCH, China CDC, gave a detailed explanation of both the activity design and baseline survey.

Regarded as a project milestone, the launch meeting was well attended and well received. Participants included staff from National Center of MCH, local government and health authorities, and directors and staff from the MCH Hospital in the pilot area.